Evidence map›Paper›PMID 38495520›Full record

ArticleEClinicalMedicine2024

Internet of things-based management versus standard management of home noninvasive ventilation in COPD patients with hypercapnic chronic respiratory failure: a multicentre randomized controlled non-inferiority trial.

Weipeng Jiang, Xiaoyan Jin, Chunling Du, Wenchao Gu, Xiwen Gao, Chenjun Zhou, Chunlin Tu, Hongqun Chen, Hong Li, Yao Shen and 11 more

Open access · goldAbstract read
In one paragraph

Article in EClinicalMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 1 country.

Weipeng JiangDepartment of Pulmonary Medicine and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Xiaoyan JinDepartment of Pulmonary Medicine, Tong Ren Hospital, Jiaotong University, Shanghai, China.
Chunling DuDepartment of Pulmonary Medicine, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
Wenchao GuDepartment of Pulmonary Medicine, Pudong New Area People's Hospital, Shanghai, China.
Xiwen GaoDepartment of Pulmonary Medicine, Minhang Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
Chenjun ZhouDepartment of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, China.
Chunlin TuDepartment of Pulmonary Medicine, Jiading District Central Hospital Affiliated Shanghai University of Medicine &Health Sciences, Shanghai, China.
Hongqun ChenDepartment of Pulmonary Medicine, Zhongshan Xuhui Hospital, Fudan University, Shanghai, China.
Hong LiDepartment of Pulmonary Medicine, Traditional Chinese Medicine Hospital of Kunshan, Jiangsu, China.
Yao ShenDepartment of Pulmonary Medicine, Pudong Hospital, Shanghai, China.
Yunfeng ZhangDepartment of Pulmonary Medicine, Putuo District Liqun Hospital, Shanghai, China.
Xiahui GeDepartment of Pulmonary Medicine, Shanghai Ninth People's Hospital, Jiaotong University, Shanghai, China.
Yingxin SunDepartment of Pulmonary Medicine, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
Lei ZhouDepartment of Pulmonary Medicine, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
Suyun YuDepartment of Pulmonary Medicine, Minhang Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
Kaishun ZhaoDepartment of Pulmonary Medicine, Jiading District Central Hospital Affiliated Shanghai University of Medicine &Health Sciences, Shanghai, China.
Qing ChengDepartment of Pulmonary Medicine, Pudong Hospital, Shanghai, China.
Xiaodan ZhuDepartment of Pulmonary Medicine and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Hongen LiaoDepartment of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, China.
Chunxue BaiDepartment of Pulmonary Medicine and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Yuanlin SongDepartment of Pulmonary Medicine and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Fudan University · CNZhongshan Hospital · CNJiading District Central Hospital · CNShanghai Pulmonary Hospital · CNTsinghua University · CNCentral Hospital of Putuo District · CNPudong New Area People's Hospital · CNRenji Hospital · CNShanghai Ninth People's Hospital · CNShanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Effective monitoring and management are crucial during long-term home noninvasive positive pressure ventilation (NPPV) in patients with hypercapnic chronic obstructive pulmonary disease (COPD). This study investigated the benefit of Internet of Things (IOT)-based management of home NPPV. Methods: This multicenter, prospective, parallel-group, randomized controlled non-inferiority trial enrolled patients requiring long-term home NPPV for hypercapnic COPD. Patients were randomly assigned (1:1), via a computer-generated randomization sequence, to standard home management or IOT management based on telemonitoring of clinical and ventilator parameters over 12 months. The intervention was unblinded, but outcome assessment was blinded to management assignment. The primary outcome was the between-group comparison of the change in health-related quality of life, based on severe respiratory insufficiency questionnaire scores with a non-inferiority margin of -5. This study is registered with Chinese Clinical Trials Registry (No. ChiCTR1800019536). Findings: Overall, 148 patients (age: 72.7 ± 6.8 years; male: 85.8%; forced expiratory volume in 1 s: 0.7 ± 0.3 L; PaCO Interpretation: Among stable patients with hypercapnic COPD, using IOT-based management for home NPPV improved health-related quality of life and prolonged the time to readmission. Funding: Air Liquide Healthcare (Beijing) Co., Ltd.

Indexed as

Chronic obstructive pulmonary diseaseHypercapnia respiratory failureInternet of thingsNoninvasive positive pressure ventilationTelemedicine

Identifiers

PMID38495520
PMCPMC10940131
OpenAlexW4392656617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.